Clinical Trial Update: Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing adjunctive corticosteroids for tuberculous meningitis in HIV-infected adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids
• Tuberculosis
• Tuberculous Meningitis

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Tuberculosis, Tuberculous Meningitis | Phase 3 | Status: COMPLETED